Recent Trends in the Use of “Club Drugs”: An Australian Review

References

• ABCI. Australian Illicit Drug Report 1998–1999. Australian Bureau of Criminal Intelligence, Canberra 2000
   Google Scholar
• Abraham M., Kaal H., Cohen P. Licit and Illicit Drug Use in the Netherlands 2001. Amsterdam: CEDRO/Mets en Schilt 2002
   Google Scholar
• Ahmed S. N., Petchovsky L. Abuse of ketamine (Letter). British Journal of Psychiatry 1980; 137: 303, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Aust R. Prevalence of Drug Use: Key Findings from the 2001/2002 British Crime Survey. Home Office, London 2002
   Google Scholar
• Australian Bureau of Criminal Intelligence. Australian Illicit Drug Report 1994. Australian Bureau of Criminal Intelligence, Canberra 1995
   Google Scholar
• Australian Bureau of Criminal Intelligence. Australian Illicit Drug Report 1998–1999. Australian Bureau of Criminal Intelligence, Canberra 2000
   Google Scholar
• Australian Institute of Health and Welfare. 2001 National Drug Strategy Household Survey: First results. Australian Institute of Health (Drug Statistics Series), Canberra 2002
   Google Scholar
• Beardsley P. M., Balster R. L. Behavioral dependence upon phencyclidine and ketamine in the rat. Journal of Pharmacology and Experimental Therapeutics 1987; 242: 203–211, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Beck F., Iegleye S., Peretti-Watel P. Survey EROPP 2002. OFDT, Paris 2003
   Google Scholar
• Bobes J., Saiz P. A., Gonzalez M. P., Bascaran M. T., Bousono M., Ricaurte G. A., McCann U. D. Use of MDMA and other illicit drugs by young adult males in northern Spain. A five-year study. European Addiction Research 2002; 8: 147–54, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bowles T., Sommi R., Amiri M. Successful management of prolonged gammahydroxybutyrate and alcohol withdrawal. Pharmacotherapy 2001; 21: 254–257, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Boys A., Marsden J., Griffiths P., Fountain J., Stillwell G., Strang J. Substance use among young people: The relationship between perceived functions and intentions. Addiction 1999; 94: 1043–1050, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Breen C., Degenhardt L., White B., Bruno R., Chanteloup F., Fischer J., Moon C., Proudfoot P., Richards J., Ward J., Weekley J. Australian Party Drug Trends 2003. University of NSW, Sydney 2004, National Drug and Alcohol Research Centre
   Google Scholar
• Breen C., Topp L., Longo M. Adapting the IDRS methodology to monitor trends in party drug markets: Findings of a two-year Feasibility trial. University of New South Wales, Sydney 2002, National Drug and Alcohol Research Centre
   Google Scholar
• Brown L. P. Pulse Check: National Trends in drug Abuse. Office of National Drug Control Policy, Washington 1995
   Google Scholar
• Budisavljevic M. N., Stewart L., Sahn S. A., Ploth D. W. Hyponatremia associated with 3,4-methylenedioxymethylamphetamine (“ecstasy”) abuse. American Journal of the Medical Sciences 2003; 326: 89–93, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Buffum J., Moser C. MDMA and human sexual function. Journal of Psychoactive Drugs 1986; 18: 355–359, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Catalano M., Glass J., Catalano G., Burrows S., Lynn W., Weitzner B. Gamma butyrolactone (GBL) withdrawal syndromes. Psychosomatics 2001; 42: 83–88, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Centre for Addiction and Mental Health. Drug use among Ontario students, 1977–2003. Centre for Addiction and Mental Health, Ontario 2003
   Google Scholar
• Chin M., Kreutzer R., Dyer J. Acute poisoning from gamma-hydroxybutyrate overdose. Annals of Emergency Medicine 1992; 31: 716–722
   Google Scholar
• Craig K., Gomez H., McManus J., Bania T. Severe gamma-hydroxybutyrate withdrawal: A case report and literature review. Journal of Emergency Medicine 2000; 18: 65–70, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Crysell A. Lost in the K-hole. Muzik. 1998; Vol. 40: pp. 45–48
   Google Scholar
• Curran V., Monaghan L. In and out of the K-hole—a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 2001; 95: 749–760, [CROSSREF]
   Google Scholar
• Curran V., Morgan C. Cognitive, dissociative and psychogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction 2000; 95: 575–590, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dalgarno P. J., Shewan D. Illicit use of ketamine in Scotland. Journal of Psychoactive Drugs 1996; 28: 191–199, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Darke S., Ross J., Hando J., Hall W., Degenhardt L. Illicit Drug Use in Australia: Monograph Series No. 43. National Drug and Alcohol Research Centre. 2000
   Google Scholar
• Degenhardt L., Barker B., Topp L. Patterns of ecstasy use in Australia: Findings from a national household survey. Addiction 2004; 99: 187–195, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Degenhardt L., Darke S., Dillon P. GHB use among Australians: Characteristics, use patterns, and associated harm. Drug and Alcohol Dependence 2002; 67: 89–94, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Degenhardt L., Darke S., Dillon P. The prevalence and correlates of GHB overdose among Australian users. Addiction 2003; 98: 199–204, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dillon P., Copeland J., Jansen K. L. R. Patterns of use and harms associated with non-medical ketamine use. Drug and Alcohol Dependence 2003; 69: 23–28, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dotson J. W., Ackerman D. L., West L. J. Ketamine abuse. Journal of Drug Issues 1995; 25: 751–757
   Web of Science ®Google Scholar
• Drug Enforcement Agency. Ketamine abuse increasing. Drug Enforcement Agency. 1997
   Google Scholar
• Dyer J., Roth B., Hyme B. Gamma-hydroxybutyrate withdrawal syndrome. Annals of Emergency Medicine 2001; 37: 147–153, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Eckstein M., Henderson S., DelaCruz P., Newton E. Gamma hydroxybutyrate (GHB): report of a mass intoxication and review of the literature. Preshospital Emergency Care 1999; 3: 357–361
   PubMedGoogle Scholar
• Ferrara S., Tedeschi L., Frison G. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication. Journal of Forensic Science 1995; 40: 501–504
   PubMed Web of Science ®Google Scholar
• Forsyth A. J. M., Barnard M., McKeganey N. P. Musical preference as an indicator of adolescent drug use. Addiction 1997; 92: 1317–1325, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Friedman J., Westlake R., Furman M. “Grievous bodily harm”: Gamma hydroxybutyrate abuse leading to the Wernicke-Korsakoff syndrome. Neurology 1996; 46: 469–471, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Galloway G., Frederick S., Staggers F., Gonzales M., Stalcup S., Smith D. Gamma-hydroxybutyrate: An emerging drug of abuse that causes physical dependency. Addiction 1997; 92: 89–96, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gill J. R., Stajic M. Ketamine in non-hospital and hospital deaths in New York City. Journal of Forensic Science 2000; 45: 655–658
   PubMed Web of Science ®Google Scholar
• Gowing L. R., Henry-Edwards S. M., Irvine R. J., Ali R. L. The health effects of ecstasy: A literature review. Drug & Alcohol Review 2002; 21: 53–63, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Griffiths P., Gossop M., Powis B., Strang J. Reaching hidden populations of drug users by privileged access interviewers: Methodological and practical issues. Addiction 1993; 88: 1617–1626, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gross S. R., Barrett S. P., Shestowsky J. S., Pihl R. O. Ecstasy and drug consumption patterns: A Canadian rave population study. Canadian Journal of Psychiatry—Revue Canadienne de Psychiatrie 2002; 47: 546–51
   PubMed Web of Science ®Google Scholar
• Hammersley R., Ditton J., Smith I., Short E. Patterns of ecstasy use by drug users. British Journal of Criminology 1999; 39: 625–647, [CROSSREF]
   Web of Science ®Google Scholar
• Hurt P. H., Ritchie E. C. A case of ketamine dependence (Letter). American Journal of Psychiatry 1994; 151: 779, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ingels M., Rangan C., Bellezo J., Clark R. Coma and respiratory depression following the ingestion of GHB and its precursors: Three cases. Journal of Emergency Medicine 2000; 19: 47–50, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jansen K. L. R. Ketamine: Can chronic use impair memory?. International Journal of Addictions 1990; 25: 133–139
   PubMed Web of Science ®Google Scholar
• Jansen K. L. R. Non-medical use of ketamine (Editorial). British Medical Journal 1993; 306: 601–602, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jansen K. L. R. Ketamine, Dreams and Realities. Multidisciplinary Association for Psychedelic Studies, Sarasota, Florida 2000
   Google Scholar
• Johnston L. D., O'Malley P. M., Bachman J. G. National Survey Results on Drug Use from the Monitoring the Future Study, 1975–2003. National Institute on Drug Abuse, Rockville, MD 2003
   Google Scholar
• Kamaya H., Krishna P. R. Ketamine addiction (Letter). Anaesthesia 1987; 67: 861–862
   Web of Science ®Google Scholar
• Karch S., Stephens B., Nazareno G. GHB: Club drug or confusing artifact?. American Journal of Forensic Medicine and Pathology 2001; 22: 268–269
   Google Scholar
• Kent J. The Ketamine Konundrum 1996, http://www.lycaeum.org/∼lux/alchem/konunb.1 accessed 6/25/97
   Google Scholar
• Kerlinger F. N. Foundations of Behavioral Research. CBS Publishing Limited, TokyoJapan 1986
   Google Scholar
• Klitzman R., Greenberg J., Pollack L., Dolezal C. MDMA (‘ecstasy’) use, and its association with high risk behaviours, mental health, and other factors among gay/bisexual men in New York City. Drug & Alcohol Dependence 2002; 66: 115–125, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Koesters S. C., Rogers P. D., Rajasingham C. R. MDMA (‘ecstasy’) and other ‘club drugs.’ The new epidemic. The Pediatric Clinics of North America 2002; 49: 415–433, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Li J., Stokes S., Woeckener A. A tale of novel intoxication: Seven cases of gamma-hydroxybutyrate acid overdose. Annals of Emergency Medicine 1998; 31: 723–728, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Lieb R., Schuetz C. G., Pfister H., von Sydow K., Wittchen H. Mental disorders in ecstasy users: A prospective-longitudinal investigation. Drug & Alcohol Dependence 2002; 68: 195–207, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lilly J. C. The Scietist: A Novel Autobiography. Bantam Books, Lippincourt, New York 1978
   Google Scholar
• Mansergh G., Colfax G. N., Marks G., Rader M., Guzman R., Buchbinder S. The Circuit Party Men's Health Survey: Findings and implications for gay and bisexual men. American Journal of Public Health 2001; 91: 953–8, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McDaniel C., Miotto K. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: Five case studies. Journal of Psychoactive Drugs 2001; 33: 143–149, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• McKetin R., Darke S., Humeniuk R., Dwyer R., Bruno R., Fleming J., Kinner S., Hargreaves K., Rysavy P. Australian Drug Trends 1999. Findings from the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, UNSW, Sydney 2000, NDARC Monograph No. 43
   Google Scholar
• Michael G. W., Hall J. N. South Florida at risk for Grievous Bodily Harm. Information for Action. Drug Surveillance News May 9, 1994
   Google Scholar
• Miotto K., Darakjian J., Basch J., Murray S., Zogg J., Rawson R. Gammahydroxybutyric acid: Patterns of use, effects and withdrawal. American Journal on Addictions 2001; 10: 232–241, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Miro O., Nogue S., Espinosa G., To-Figueras J., Sanchez M. Trends in illicit drug emergencies: The emerging role of gamma-hydroxybutyrate. Journal of Toxicology—Clinical Toxicology 2002; 40: 129–35, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Moore N. N., Bostwick J. M. Ketamine dependence in anesthesia providers. Psychosomatics 1999; 40: 356–359, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Muller A. GHB poisoning: Three recent cases reflect the continuing danger. Journal of Emergency Nursing 2003; 29: 72–74, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• National Advisory Committee on Drugs and Drug and Alcohol Information and Research Unit. Drug use in Ireland and Northern Ireland: First results from the 2002/2003 drug prevalence survey 2003
   Google Scholar
• National Plan on Drugs. Household Survey on Drugs 2001. Spain 2001
   Google Scholar
• New York State Office of Alcoholism and Substance Abuse Service. Ketamine Update. Bureau of Applied Studies—Street Studies Unit, New York 1997
   Google Scholar
• Nicholson K., Balster R. GHB: A new and novel drug of abuse. Drug and Alcohol Dependence 2001; 63: 1–22, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Parke-Davis. Parke-Davis Product information Sheet: Ketalar. ABPI Compendium of Data Sheets and Summaries of Product Characteristics. Datapharm Publications. 1999–2000
   Google Scholar
• Parrott A. C., Buchanan T., Scholey A. B., Heffernan T., Ling J., Rodgers J. Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users. Human Psychopharmacology 2002; 17: 309–312, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Parrott A. C., Milani R. M., Parmar R., Turner J. D. Recreational ecstasy/MDMA and other drug users from the UK and Italy: Psychiatric symptoms and psychobiological problems. Psychopharmacology 2001; 159: 77–82, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Pierce P. A., Peroutka S. Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex. Neuroscience Letters 1988; 95: 208–212, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Sanguineti V., Angelo A., Frank M. GHB: A home brew. American Journal of Drug & Alcohol Abuse 1997; 23: 637–642
   PubMed Web of Science ®Google Scholar
• Schneir A., Ly B., Clark R. A case of withdrawal from the GHB precursors gammabutyrolactone and 1,4-butanediol. Journal of Emergency Medicine 2001; 21: 31–33, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sherlock K., Wolff K., Hay A., Conner M. Analysis of illicit ecstasy tablets: Implications for clinical management in the accident and emergency department. Journal of Accident & Emergency Medicine 1999; 16(3)194–197
   PubMedGoogle Scholar
• Skovmand K. Swedes alarmed at ketamine misuse. The Lancet 1996; 348: 122, [CROSSREF]
   Web of Science ®Google Scholar
• Solowij N., Hall W., Lee N. Recreational MDMA use in Sydney: A profile of ‘ecstacy’ users and their experiences with the drug. British Journal of Addiction 1992; 87: 1161–1172, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Soyka M., Krupinski G., Volki G. Phenomenology of ketamine induced psychosis. Sucht 1993; 5: 327–331
   Google Scholar
• Sprague J., Everman S., Nichols D. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 1998; 19: 427–441, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sputz R. I never met a reality I did not like: A report on ‘vitamin K’. High Times. 1989; Vol. October: pp. 64–82
   Google Scholar
• Strote J., Lee J. E., Wechsler H. Increasing MDMA use among college students: Results of a national survey. Journal of Adolescent Health 2002; 30: 64–72, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2001 National Household Survey on Drug Abuse: Volume I. Summary of National Findings. SAMHSA, US Department of Health and Human Services, Rockville, MD 2002
   Google Scholar
• Thomas G., Bonner S., Gascoigne A. Coma induced by abuse of gamma-hydroxybutyrate (GBH or liquid ecstasy): A case report. British Medical Journal 1997; 314: 35, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Topp L., Barker B., Degenhardt L. The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug & Alcohol Dependence 2004; 73: 33–40, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Topp L., Breen C., Kaye S., Darke S. NSW Party Drug Trends 2001. Findings from the Illicit Drug Reporting System (IDRS) Party Drugs Module. National Drug and Alcohol Research Centre, UNSW., Sydney, NSW 2002a, NDARC technical report No. 136
   Google Scholar
• Topp L., Darke S. NSW Party Drug Trends 2000: Findings of the illicit Drug Reporting System Party Drugs Module. University of New South Wales, Sydney 2001, National Drug and Alcohol Research Centre
   Google Scholar
• Topp L., Hando J., Degenhardt L., Dillon P., Roche A., Solowij N. Ecstasy Use in Australia. National Drug and Alcohol Research Centre, Sydney 1997, NDARC Monograph No. 39
   Google Scholar
• Topp L., Hando J., Degenhardt L., Dillon P., Roche A., Solowij N. Ecstasy use in Australia. National Drug and Alcohol Research Centre, Sydney 1998, Monograph No. 39
   Google Scholar
• Topp L., Hando J., Dillon P., Roche A., Solowij N. Ecstasy use in Australia: Patterns of use and associated harm. Drug and Alcohol Dependence 1999; 55: 105–115, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Topp L., Kaye S., Bruno R., Hargreaves K., Longo M., Williams P., O'Reilly B., Fry C., Rose G., Darke S. Australian Drug Trends 2001: Findings of the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, UNSW., Sydney 2002b, NDARC Monograph No. 48
   Google Scholar
• Tori S. P. Ketamine Abuse. ‘Special K.’ Middle Atlantic-Great Lakes Organized Crime Law Enforcement Network (MAGLOCLEN), Pennsylvania 1996
   Google Scholar
• Turner D. M. The Essential Guide to Psychedelics. Panther Press, Frederick, MD 1994
   Google Scholar
• United States Department of Health and Human Services. Gamma hydroxybutyrate use—New York and Texas, 1995–1996. Morbidity and Mortality Weekly Report 1997; 46: 281–283
   PubMedGoogle Scholar
• U.S. Drug Enforcement Agency. Drug Intelligence Brief—Club Drugs: An Update. Vol. 2002. 2001, DEA Intelligence Division, Office of Domestic Intelligence, Domestic Strategy Unit
   Google Scholar
• von Sydow K., Lieb R., Pfister H., Hofler M., Wittchen H. U. Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults—a transient phenomenon? Results from a longitudinal community study. Drug & Alcohol Dependence 2002; 66: 147–59, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Weiner A. L., Vieira L., Mckay C. A., Bayer M. J. Ketamine abusers presenting to the Emergency Department: A case series. Journal of Emergency Medicine 2000; 18: 447–451, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Weir E. Raves: A review of the culture, the drugs and the prevention of harm. Canadian Medical Association Journal 2000; 162: 1843–1848, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• White B., Breen C., Degenhardt L. New South Wales Party Drugs Trends 2002: Findings from the Illicit Drug Reporting System (IDRS) Party Drugs Module. University of New South Wales, Sydney 2003, National Drug and Alcohol Research Centre
   Google Scholar
• White B., Breen C., Degenhardt L. New South Wales Party Drug Trends 2003: Findings of the Party Drugs Initiative. Sydney, University of NSW 2004, National Drug and Alcohol Research Centre
   Google Scholar
• White J. M., Bochner F., Irvine R. J. The agony of “ecstasy”—How can we avoid more “ecstasy”-related deaths?. MJA 1997; 166: 117, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• White J. M., Ryan C. F. Pharmacological properties of ketamine. Drug and Alcohol Review 1996; 15: 145–155
   PubMed Web of Science ®Google Scholar
• Whitten L. Conference highlights increasing GHB abuse. NIDA Notes 2001; 16: 10–11, [CROSSREF]
   Google Scholar
• Wilkins C., Casswell S., Bhatta K., Pledger M. Drug use in New Zealand: National surveys comparison 1998 and 2001. Alcohol and Public Health Research Unit, Auckland 2002
   Google Scholar
• Williamson S., Gossop M., Powis B., Griffiths P., Fountain J., Strang J. Adverse effects of stimulant drugs in a community sample of drug users. Drug and Alcohol Dependence 1997; 44: 87–94, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Winstock A. R., Griffiths P., Stewart D. Drugs and the dance music scene: A survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug & Alcohol Dependence 2001; 64: 9–17, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zemishlany Z., Aizenberg D., Weizman A. Subjective effects of MDMA (‘ecstasy’) on human sexual function. European Psychiatry 2001; 16: 127–130, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar